How much do superbugs cost Australian hospitals

Slides:

Advertisements

Similar presentations

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.

Advertisements

Temperature and Humidity Effects on Hospital Morbidity in Darwin, Australia James Goldie, BSc (Adv) (Hons), MBus (S&T), Steven C. Sherwood, BSc, MSc, PhD,

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

2002 Air Medical Transport Industry Awards Air Medical Journal Volume 22, Issue 2, Pages (March 2003) DOI: /S X(03) Copyright.

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

An economic analysis of the benefits of sterilizing medical instruments in low- temperature systems instead of steam Victoria McCreanor, LLB, MSc, Nicholas.

2001: A Nursing Odyssey Nursing for Women's Health

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

I.J. Schalk Clinical Microbiology and Infection

A pilot study on improving the appropriateness of urine specimen collection among catheterised patients in acute aged care Jan Gralton, Belinda Boston,

Herpes zoster in non-hospitalized children

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

Using Dynamic Transmission Modeling to Determine Vaccination Coverage Rate Based on 5-Year Economic Burden of Infectious Disease: An Example of Pneumococcal.

Is antimicrobial stewardship cost-effective

Clinical impact of antibiotic-resistant Gram-positive pathogens

Brett G. Mitchell, Anthony Williams, Zorana Wong, Jayne O'Connor

Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals

A student-led progressive resistance training program increases lower limb muscle strength in adolescents with Down syndrome: a randomised controlled.

Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan P.R. Hsueh, S.P. Tseng, L.J. Teng, S.W. Ho

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Looking to the future in Latvia

Diana Khuu, Mark L. Eberhard, Benjamin N

Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective J.A. Otter, P. Burgess,

This Month in AJKD American Journal of Kidney Diseases

Effect of development assistance on domestic health expenditures

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

Luigi Naldi Journal of Investigative Dermatology

Epidemiology of opportunistic infections in AIDS patients

Artificial Intelligence for infectious disease Big Data Analytics

Anindita Das, Karina Kennedy, Gloria Spyropoulos, Peter Collignon

Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan P.-R. Hsueh, J.-M. Shyr, J.-J. Wu Clinical.

Cardiovascular Disease in Women of Reproductive Age

G.S. Whiteley, T.O. Glasbey, P.P. Fahey Infection, Disease & Health

Practice Notes from the AAAAI

Economics of Exercise Nursing for Women's Health

Anindita Das, Karina Kennedy, Gloria Spyropoulos, Peter Collignon

Symposia and Oral Presentations

Neuromuscular junction in health and disease

Zika virus infection: Some issues of urgent attention

Eugene M. Tan, Jasmine R. Marcelin, Abinash Virk

Volume 4, Issue 5, Pages 2-3 (October 2006)

Thomas G. Heazlewood, Kathryn Ogden, Damhnat McCann

Point prevalence surveys of healthcare-associated urinary tract infections: Development, pilot testing and evaluation of face-to-face and online educational.

V. Vlahović-Palčevski, U. Dumpis, P. Mitt, J. Gulbinovič, J. Struwe, G

“It's in your hands – Prevent sepsis in health care”; 5th May 2018 World Health Organization (WHO) SAVE LIVES: Clean Your Hands campaign Hiroki Saito

Volume 17, Issue 2, Pages (February 1950)

C. Wongsrichanalai, C.H. Sibley Clinical Microbiology and Infection

Artefenomel: a promising new antimalarial drug

W. Eugene Sanders, Christine C. Sanders

Sexually Transmitted Infections in Pregnancy

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

The unprecedented magnitude of the 2017 dengue outbreak in Sri Lanka provides lessons for future mosquito-borne infection control and prevention Shahid.

Organization news Archives of Physical Medicine and Rehabilitation

“It's in your hands – Prevent sepsis in health care”; 5th May 2018 World Health Organization (WHO) SAVE LIVES: Clean Your Hands campaign Hiroki Saito

Systematic review of the impact of osteoarthritis on health outcomes for comorbid disease in older people L. Parkinson, D.L. Waters, L. Franck Osteoarthritis.

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

This Month in AJKD American Journal of Kidney Diseases

This Month in AJKD American Journal of Kidney Diseases

Practice Notes from the AAAI

Getting into Nursing Research

Volume 4, Issue 3, Pages (March 2018)

Volume 4, Issue 1, Pages 2-3 (February 2006)

Systems Biophysics: Multiscale Biophysical Modeling of Organ Systems

Volume 2, Issue 6, Pages (June 2017)

Effectiveness of insertion and maintenance bundles in preventing peripheral intravenous catheter-related complications and bloodstream infection in hospital.

This Month in AJKD American Journal of Kidney Diseases

Volume 3, Issue 5, Pages (November 2017)

Presentation transcript:

How much do superbugs cost Australian hospitals How much do superbugs cost Australian hospitals? An evidence-based open-access tool Teresa M. Wozniak, Nicholas Graves, Adrian G. Barnett Infection, Disease & Health Volume 23, Issue 1, Pages 54-56 (March 2018) DOI: 10.1016/j.idh.2017.11.002 Copyright © 2017 The Authors Terms and Conditions

Diagram 1 Pictorial representation of the economic model used to estimate the cost of drug resistant infections in Australia. Infection, Disease & Health 2018 23, 54-56DOI: (10.1016/j.idh.2017.11.002) Copyright © 2017 The Authors Terms and Conditions